Stephen Jensik to Risk Factors
This is a "connection" page, showing publications Stephen Jensik has written about Risk Factors.
Connection Strength
0.100
-
Graft repair of arteriovenous fistula aneurysms is associated with decreased long-term patency. Am J Surg. 2022 07; 224(1 Pt A):136-140.
Score: 0.032
-
Efficacy and safety of bleselumab in kidney transplant recipients: A phase 2, randomized, open-label, noninferiority study. Am J Transplant. 2020 01; 20(1):159-171.
Score: 0.027
-
Arteriovenous fistula patency in the 3?years following vonapanitase and placebo treatment. J Vasc Surg. 2017 Apr; 65(4):1113-1120.
Score: 0.022
-
A prospective, randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 1 year. Transplantation. 2005 Aug 15; 80(3):303-9.
Score: 0.010
-
Randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 6 months. Transplantation. 2003 Apr 27; 75(8):1213-20.
Score: 0.009